These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22813440)

  • 1. Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease.
    Ordás I; Feagan BG; Sandborn WJ
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1079-87; quiz e85-6. PubMed ID: 22813440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms.
    Ordás I; Mould DR; Feagan BG; Sandborn WJ
    Clin Pharmacol Ther; 2012 Apr; 91(4):635-46. PubMed ID: 22357456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of bioavailability, pharmacokinetics and immunogenicity of tumour necrosis factor-alpha inhibitors].
    Steenholdt C; Ainsworth M; Thomsen OØ; Brynskov J; Bendtzen K
    Ugeskr Laeger; 2010 Jan; 172(1):44-7. PubMed ID: 20056095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice.
    Vande Casteele N; Gils A
    J Clin Pharmacol; 2015 Mar; 55 Suppl 3():S39-50. PubMed ID: 25707962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of biological molecules in the treatment of inflammatory bowel disease.
    Nielsen OH; Seidelin JB; Munck LK; Rogler G
    J Intern Med; 2011 Jul; 270(1):15-28. PubMed ID: 21241384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.
    Khanna R; Sattin BD; Afif W; Benchimol EI; Bernard EJ; Bitton A; Bressler B; Fedorak RN; Ghosh S; Greenberg GR; Marshall JK; Panaccione R; Seidman EG; Silverberg MS; Steinhart AH; Sy R; Van Assche G; Walters TD; Sandborn WJ; Feagan BG
    Aliment Pharmacol Ther; 2013 Sep; 38(5):447-59. PubMed ID: 23848220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.
    de Silva PS; Nguyen DD; Sauk J; Korzenik J; Yajnik V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2012 Sep; 36(5):459-66. PubMed ID: 22784296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug monitoring of biologics in inflammatory bowel disease.
    Eser A; Primas C; Reinisch W
    Curr Opin Gastroenterol; 2013 Jul; 29(4):391-6. PubMed ID: 23703367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Papamichael K; Vande Casteele N; Ferrante M; Gils A; Cheifetz AS
    Inflamm Bowel Dis; 2017 Sep; 23(9):1510-1515. PubMed ID: 28816757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized therapy with TNF-inhibitors in Crohn's disease: optimizing treatment outcomes by monitoring drug levels and anti-drug antibodies.
    Steenholdt C
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
    Rutgeerts P; Vermeire S; Van Assche G
    Gut; 2007 Apr; 56(4):453-5. PubMed ID: 17369375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis.
    Qiu Y; Mao R; Chen BL; Zhang SH; Guo J; He Y; Zeng ZR; Ben-Horin S; Chen MH
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1359-1372.e6. PubMed ID: 28232073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
    Yarur AJ; Rubin DT
    Inflamm Bowel Dis; 2015 Jul; 21(7):1709-18. PubMed ID: 25901974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Miheller P; Kiss LS; Lorinczy K; Lakatos PL
    Expert Opin Biol Ther; 2012 Feb; 12(2):179-92. PubMed ID: 22149260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of biologics for inflammatory bowel disease.
    Colombel JF; Feagan BG; Sandborn WJ; Van Assche G; Robinson AM
    Inflamm Bowel Dis; 2012 Feb; 18(2):349-58. PubMed ID: 22021134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do not assume symptoms indicate failure of anti-tumor necrosis factor therapy in Crohn's disease.
    Bruining DH; Sandborn WJ
    Clin Gastroenterol Hepatol; 2011 May; 9(5):395-9. PubMed ID: 21277392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.
    Strik AS; Bots SJ; D'Haens G; Löwenberg M
    Expert Rev Clin Pharmacol; 2016; 9(3):429-39. PubMed ID: 26681400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art: Immunosuppression and biologic therapy.
    Sandborn WJ
    Dig Dis; 2010; 28(3):536-42. PubMed ID: 20926883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
    Melmed GY; Irving PM; Jones J; Kaplan GG; Kozuch PL; Velayos FS; Baidoo L; Sparrow MP; Bressler B; Cheifetz AS; Devlin SM; Raffals LE; Vande Casteele N; Mould DR; Colombel JF; Dubinsky M; Sandborn WJ; Siegel CA
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1302-9. PubMed ID: 27189916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease.
    Ben-Horin S; Waterman M; Kopylov U; Yavzori M; Picard O; Fudim E; Awadie H; Weiss B; Chowers Y
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):444-7. PubMed ID: 23103905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.